Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Withdrawn 1

Sponsor Class

OTHER 2NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Leukemia 52Leukemia, Myeloid, Acute 30Precursor Cell Lymphoblastic Leukemia-Lymphoma 28Lymphoma 23Burkitt Lymphoma 16Leukemia, Monocytic, Acute 15Leukemia, Myelomonocytic, Acute 14Leukemia, Megakaryoblastic, Acute 14Leukemia, Erythroblastic, Acute 14Congenital Abnormalities 12Leukemia, Biphenotypic, Acute 9Myelodysplastic Syndromes 7Lymphoma, Large B-Cell, Diffuse 6Lymphoma, Non-Hodgkin 4Lymphoma, Mantle-Cell 4Leukemia, Eosinophilic, Acute 4Hodgkin Disease 4Dendritic Cell Sarcoma, Interdigitating 4Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 3Lymphoma, Large-Cell, Anaplastic 3Lymphoma, Follicular 3Leukemia, Basophilic, Acute 3Anemia, Refractory, with Excess of Blasts 3Waldenstrom Macroglobulinemia 2Recurrence 2Neutropenia 2Myeloproliferative Disorders 2Lymphoma, T-Cell 2Lymphoma, Large-Cell, Immunoblastic 2

Interventions

Etoposide 2ibritumomab tiuxetan 1Vincristine 1Rituximab 1Radiotherapy 1Radioimmunotherapy 1Procarbazine 1Prednisone 1Methylprednisolone 1Lomustine 1Immunization, Passive 1Drug Therapy 1Doxorubicin 1Cytarabine 1Cyclophosphamide 1Cisplatin 1Biological Therapy 1Antibodies, Monoclonal 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Lymphoma, AIDS-Related × Cytarabine × Clear all
NCT00310128 2016-02-03

Combination Chemotherapy Followed by Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed or Refractory AIDS-Related Non-Hodgkin's Lymphoma

AIDS Malignancy Consortium

Phase 2 Withdrawn
Lymphoid

Burkitt Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, AIDS-Related, Lymphoma, Large-Cell, Anaplastic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡